Previous close | 2.2700 |
Open | 2.2700 |
Bid | 0.0000 |
Ask | 3.4000 |
Strike | 135.00 |
Expiry date | 2025-01-17 |
Day's range | 2.2700 - 2.2700 |
Contract range | N/A |
Volume | |
Open interest | 1 |
Discover how Stryker Corp achieved significant sales growth and raised its full-year forecasts amidst dynamic market conditions.
Stryker Corp lifted its full-year profit forecast on Tuesday, owing to resilient demand for the company's medical devices and implants. The joint-implant maker now sees its annual profit per share to be between $11.85 and $12.05, raised from the previous range of between $11.70 and $12. Stryker now expects organic net sales growth for 2024 to be in the range of 8.5% to 9.5%, compared with its earlier projected range of 7.5% to 9%.